|
1
|
Duffield JS: Cellular and molecular
mechanisms in kidney fibrosis. J Clin Invest. 124:2299–2306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boor P and Floege J: The renal (myo-)
fibroblast: a heterogeneous group of cells. Nephrol Dial
Transplant. 27:3027–3036. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grgic I, Duffield JS and Humphreys BD: The
origin of interstitial myofibroblasts in chronic kidney disease.
Pediatr Nephrol. 27:183–193. 2012. View Article : Google Scholar
|
|
4
|
Bellini A and Mattoli S: The role of the
fibrocyte, a bone marrow-derived mesenchymal progenitor, in
reactive and reparative fibroses. Lab Invest. 87:858–870. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pilling D and Gomer RH: Differentiation of
circulating monocytes into fibroblast-like cells. Methods Mol Biol.
904:191–206. 2012.PubMed/NCBI
|
|
6
|
Iwano M, Plieth D, Danoff TM, Xue C, Okada
H and Neilson EG: Evidence that fibroblasts derive from epithelium
during tissue fibrosis. J Clin Invest. 110:341–350. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Deane JA, Campanale NV, Bertram JF
and Ricardo SD: The contribution of bone marrow-derived cells to
the development of renal interstitial fibrosis. Stem Cells.
25:697–706. 2007. View Article : Google Scholar
|
|
8
|
Sakai N, Wada T, Yokoyama H, et al:
Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling
regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA.
103:14098–14103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen G, Lin SC, Chen J, et al: CXCL16
recruits bone marrow-derived fibroblast precursors in renal
fibrosis. J Am Soc Nephrol. 22:1876–1886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reich B, Schmidbauer K, Rodriguez Gomez M,
et al: Fibrocytes develop outside the kidney but contribute to
renal fibrosis in a mouse model. Kidney Int. 84:78–89. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang J, Lin SC, Chen G, et al: Adiponectin
promotes monocyte-to-fibroblast transition in renal fibrosis. J Am
Soc Nephrol. 24:1644–1659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oba S, Suzuki E, Nishimatsu H, et al:
Renoprotective effect of erythropoietin in ischemia/reperfusion
injury: possible roles of the Akt/endothelial nitric oxide
synthase-dependent pathway. Int J Urol. 19:248–255. 2012.
View Article : Google Scholar
|
|
13
|
Kaynar K, Aliyazioglu R, Ersoz S, et al:
Role of erythropoietin in prevention of amikacin-induced
nephropathy. J Nephrol. 25:744–749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang W and Zhang J: Protective effect of
erythropoietin against aristolochic acid-induced apoptosis in renal
tubular epithelial cells. Eur J Pharmacol. 588:135–140. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Imamura R, Isaka Y, Sandoval RM, et al: A
nonerythropoietic derivative of erythropoietin inhibits
tubulointerstitial fibrosis in remnant kidney. Clin Exp Nephrol.
16:852–862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen CL, Chou KJ, Lee PT, et al:
Erythropoietin suppresses epithelial to mesenchymal transition and
intercepts Smad signal transduction through a MEK-dependent
mechanism in pig kidney (LLC-PK1) cell lines. Exp Cell Res.
316:1109–1118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kitamura H, Isaka Y, Takabatake Y, et al:
Nonerythropoietic derivative of erythropoietin protects against
tubulointerstitial injury in a unilateral ureteral obstruction
model. Nephrol Dial Transplant. 23:1521–1528. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park SH, Choi MJ, Song IK, et al:
Erythropoietin decreases renal fibrosis in mice with ureteral
obstruction: role of inhibiting TGF-beta-induced
epithelial-to-mesenchymal transition. J Am Soc Nephrol.
18:1497–1507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chevalier RL, Forbes MS and Thornhill BA:
Ureteral obstruction as a model of renal interstitial fibrosis and
obstructive nephropathy. Kidney Int. 75:1145–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grande MT, Fuentes-Calvo I, Arévalo M, et
al: Deletion of H-Ras decreases renal fibrosis and myofibroblast
activation following ureteral obstruction in mice. Kidney Int.
77:509–518. 2010. View Article : Google Scholar
|
|
21
|
Kim DH, Moon SO, Jung YJ, et al: Mast
cells decrease renal fibrosis in unilateral ureteral obstruction.
Kidney Int. 75:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, Huang L, Sung SS, et al: The
chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage
trafficking in kidney ischemia-reperfusion injury. Kidney Int.
74:1526–1537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Formentini I, Bobadilla M, Haefliger C, et
al: Current drug development challenges in chronic kidney disease
(CKD) - identification of individualized determinants of renal
progression and premature cardiovascular disease (CVD). Nephrol
Dial Transplant. 27(Suppl 3): iii81–iii88. 2012. View Article : Google Scholar
|
|
24
|
Strutz F and Zeisberg M: Renal fibroblasts
and myofibroblasts in chronic kidney disease. J Am Soc Nephrol.
17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meran S and Steadman R: Fibroblasts and
myofibroblasts in renal fibrosis. Int J Exp Pathol. 92:158–167.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kriz W, Kaissling B and Le Hir M:
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or
fantasy? J Clin Invest. 121:468–474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Broekema M, Harmsen MC, van Luyn MJ, et
al: Bone marrow-derived myofibroblasts contribute to the renal
interstitial myofibroblast population and produce procollagen I
after ischemia/reperfusion in rats. J Am Soc Nephrol. 18:165–175.
2007. View Article : Google Scholar
|
|
28
|
Niedermeier M, Reich B, Rodriguez Gomez M,
et al: CD4+ T cells control the differentiation of Gr1+ monocytes
into fibrocytes. Proc Natl Acad Sci USA. 106:17892–17897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bucala R, Spiegel LA, Chesney J, Hogan M
and Cerami A: Circulating fibrocytes define a new leukocyte
subpopulation that mediates tissue repair. Mol Med. 1:71–81.
1994.PubMed/NCBI
|
|
30
|
Wada T, Sakai N, Matsushima K and Kaneko
S: Fibrocytes: a new insight into kidney fibrosis. Kidney Int.
72:269–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chung AC and Lan HY: Chemokines in renal
injury. J Am Soc Nephrol. 22:802–809. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Phillips RJ, Burdick MD, Hong K, et al:
Circulating fibrocytes traffic to the lungs in response to CXCL12
and mediate fibrosis. J Clin Invest. 114:438–446. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Boor P, Ostendorf T and Floege J: Renal
fibrosis: novel insights into mechanisms and therapeutic targets.
Nat Rev Nephrol. 6:643–656. 2010. View Article : Google Scholar : PubMed/NCBI
|
